Oncternal Therapeutics, Inc.: 10-Q filed 2013-11-12
What Oncternal Therapeutics, Inc. reported in its quarterly report filed 2013-11-12 (fiscal Q3 2013): 25 published measures, 64 facts as tagged in accession 0001104659-13-083462.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-11-12
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001104659-13-083462 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Oncternal Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 22,492,000 | USD | |
| At 2012-12-31 | 57,774,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 16,938,000 | USD | |
| At 2012-12-31 | 47,701,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 19,283,000 | USD | |
| At 2012-12-31 | 48,044,000 | USD | |
| At 2012-09-30 | 38,731,000 | USD | |
| At 2011-12-31 | 63,745,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -8,937,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -34,321,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 5,101,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -16,360,000 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -36,320,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -27,044,000 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 32,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 125,000 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 1,221,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 15,000 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 6,338,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 2,015,000 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -447,570,000 | USD | |
| At 2012-12-31 | -413,249,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -5,812,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -6,548,000 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 217,000 | USD | |
| At 2012-12-31 | 507,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 2,227,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 1,878,000 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -8,960,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -34,420,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -12,763,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -36,823,000 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 21,788,000 | USD | |
| At 2012-12-31 | 56,815,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 5,165,000 | USD | |
| At 2012-12-31 | 9,495,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 1,253,000 | USD | |
| At 2012-12-31 | 1,707,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 8,960,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 34,420,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 12,763,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 36,823,000 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 63,185,389 | shares | |
| At 2012-12-31 | 62,818,424 | shares |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 389,000 | USD | |
| At 2012-12-31 | 578,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 830,000 | USD | |
| At 2012-12-31 | 726,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -8,937,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -34,321,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -12,810,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -36,809,000 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 2,483,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 8,190,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 2,999,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 7,987,000 | USD | 274 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 333,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 596,000 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 23,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 99,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -47,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 14,000 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -454,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -12,000 | USD | 274 |
Inspect the source
- Entity
- Oncternal Therapeutics, Inc. / CIK 0001260990
- Captured
- 2026-09-21T17:18:09.927Z
- SEC response SHA-256
dcefea30a8ce148cff96c2a2fa09a3b61a34c7954f6f1a0e51956fda420a1d49
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001260990.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))